Business

November 19, 2013 9:45 AM

Horizon Pharma acquires U.S. rights to Pozen drug Vimovo

Pozen announced Tuesday that Horizon Pharma USA will acquire U.S. rights to Vimovo, an arthritis pain reliever, from AstraZeneca.

Related content

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs